Total Payments
$494.77
2024 Payments
$197.58
Companies
15
Transactions
23
Medicare Patients
6,965
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$494.77 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $494.77 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $84.07 | 4 | $0 (2024) |
| GENZYME CORPORATION | $61.33 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $45.70 | 2 | $0 (2024) |
| ABBVIE INC. | $41.67 | 2 | $0 (2023) |
| Fresenius Kabi USA, LLC | $39.91 | 2 | $0 (2023) |
| UCB, Inc. | $35.25 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.92 | 1 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $24.69 | 1 | $0 (2024) |
| VYNE Pharmaceuticals Inc. | $22.67 | 1 | $0 (2020) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $22.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.58 | 9 | Incyte Corporation ($58.74) |
| 2023 | $162.69 | 7 | Fresenius Kabi USA, LLC ($39.91) |
| 2022 | $16.61 | 1 | Lilly USA, LLC ($16.61) |
| 2021 | $33.58 | 2 | GENZYME CORPORATION ($33.58) |
| 2020 | $32.57 | 2 | VYNE Pharmaceuticals Inc. ($22.67) |
| 2019 | $16.49 | 1 | AbbVie, Inc. ($16.49) |
| 2018 | $35.25 | 1 | UCB, Inc. ($35.25) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.88 | General |
| Category: Dermatology | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Genetic Disease | ||||||
| 06/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Immunology | ||||||
| 05/29/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| Category: Dermatology | ||||||
| 02/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Immunology | ||||||
| 12/20/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Monoclonal Antibody | ||||||
| 11/15/2023 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Biosimilars | ||||||
| 08/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2023 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $18.45 | General |
| 07/17/2023 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Biosimilars | ||||||
| 01/30/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.33 | General |
| Category: Dermatology | ||||||
| 11/07/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Immunology | ||||||
| 11/23/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Immunology | ||||||
| 06/08/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Immunology | ||||||
| 10/15/2020 | VYNE Pharmaceuticals Inc. | AMZEEQ (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Treatment of ACNE Vulgaris | ||||||
| 02/06/2020 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $9.90 | General |
| Category: DERMATOLOGY | ||||||
| 05/13/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Immunology | ||||||
| 07/30/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $35.25 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,517 | 1,862 | $1.3M | $494,123 |
| 2022 | 24 | 1,670 | 2,018 | $1.6M | $605,320 |
| 2021 | 26 | 1,944 | 2,316 | $1.6M | $622,529 |
| 2020 | 24 | 1,834 | 2,222 | $1.5M | $578,376 |
Total Patients
6,965
Total Services
8,418
Medicare Billing
$2.3M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 382 | 494 | $606,558 | $247,745 | 40.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 196 | 322 | $239,636 | $106,978 | 44.6% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 39 | 41 | $57,584 | $25,178 | 43.7% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 135 | 153 | $79,664 | $17,578 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 206 | 241 | $39,928 | $17,227 | 43.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 99 | 109 | $63,253 | $14,022 | 22.2% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 17 | 17 | $31,036 | $13,645 | 44.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 19 | 19 | $21,877 | $9,523 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 101 | 101 | $20,653 | $8,499 | 41.2% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2023 | 44 | 45 | $35,540 | $7,789 | 21.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 86 | 96 | $9,722 | $4,264 | 43.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 28 | 30 | $16,859 | $4,065 | 24.1% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 18 | 19 | $17,673 | $4,061 | 23.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $11,919 | $2,592 | 21.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 19 | 20 | $11,381 | $2,515 | 22.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 47 | 54 | $10,136 | $2,454 | 24.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $9,644 | $2,113 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 15 | $3,519 | $1,405 | 39.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 32 | $3,070 | $1,299 | 42.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 15 | 15 | $1,793 | $623.14 | 34.8% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 13 | $2,350 | $548.80 | 23.4% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 466 | 576 | $707,242 | $287,297 | 40.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 259 | 445 | $331,173 | $149,302 | 45.1% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2022 | 46 | 49 | $68,820 | $30,905 | 44.9% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 43 | 45 | $51,813 | $22,547 | 43.5% |
About Dr. Kent Krach, MD
Dr. Kent Krach, MD is a MOHS-Micrographic Surgery healthcare provider based in Clinton Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437133097.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kent Krach, MD has received a total of $494.77 in payments from pharmaceutical and medical device companies, with $197.58 received in 2024. These payments were reported across 23 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($494.77).
As a Medicare-enrolled provider, Krach has provided services to 6,965 Medicare beneficiaries, totaling 8,418 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Clinton Township, MI
- Active Since 12/06/2005
- Last Updated 07/28/2021
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1437133097
Products in Payments
- DUPIXENT (Biological) $107.03
- OPZELURA (Drug) $84.07
- IDACIO (Biological) $39.91
- Cimzia (Drug) $35.25
- SPEVIGO (Drug) $33.92
- SKYRIZI (Biological) $25.18
- GIVLAARI (Drug) $24.69
- AMZEEQ (Drug) $22.67
- Odomzo (Drug) $22.40
- Poteligeo (Drug) $19.90
- TREMFYA (Drug) $18.30
- TALTZ (Drug) $16.61
- Humira (Biological) $16.49
- AMELUZ (Drug) $9.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.